ReviewScientifica2026
Transforming Epilepsy Care: A Comprehensive Review of Technological Innovations, Artificial Intelligence Advancements, and Precision Tools for Enhanced Seizure Management and Patient Outcomes.
Review in Scientifica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intranasal Biodegradable Nanomedicine for Epilepsy Management: Targeting the Brain Beyond the Blood-Brain Barrier.International journal of nanomedicine · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epilepsy is a neurological disorder characterized by repeated, unprovoked seizures arising from abnormal electrical activity in the brain. The management of epilepsy presents several significant challenges. One of these challenges involves drug resistance, where seizures persist despite treatment with multiple antiepileptic drugs, requiring a tailored approach often involving complex medication regimens or alternative therapies. Additionally, antiepileptic medications can cause a range of side effects, from minor discomfort to severe complications, which can affect patient adherence and overall well-being. Accurate classification and diagnosis of seizures are crucial yet complex, potentially resulting in misdiagnosis and inappropriate treatments. These challenges can be addressed through the utilization of medical devices. A comprehensive assessment of medical apparatuses is utilized in the management of epilepsy, focusing on both implanted and non-invasive technologies. This examination encompasses implanted devices, such as neuromodulators, which are surgically inserted to address seizures in individuals with epilepsy who are resistant to pharmaceutical treatment, as well as noninvasive devices, including wearable technologies and mobile applications. These noninvasive devices enhance seizure detection and monitoring by leveraging advancements in electroencephalography, allowing for real-time data collection. Consequently, there has been an improvement in diagnostic precision and the facilitation of tailored treatment approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.